294 related articles for article (PubMed ID: 36709836)
1. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
2. A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells.
Wu C; Zhang F; Li B; Li Z; Xie X; Huang Y; Yao Z; Chen Y; Ping Y; Pan W
Small; 2023 Oct; 19(41):e2301600. PubMed ID: 37328445
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug.
Huang Y; Lin Y; Li B; Zhang F; Zhan C; Xie X; Yao Z; Wu C; Ping Y; Shen J
Asian J Pharm Sci; 2023 Sep; 18(5):100844. PubMed ID: 37915761
[TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
5. Photo-responsive prodrug nanoparticles for efficient cytoplasmic delivery and synergistic photodynamic-chemotherapy of metastatic triple-negative breast cancer.
Jiao J; Lu H; Wang S
Acta Biomater; 2021 May; 126():421-432. PubMed ID: 33774201
[TBL] [Abstract][Full Text] [Related]
6. A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy.
Wang N; Zhang Q; Wang Z; Liu Y; Yang S; Zhao X; Peng J
Carbohydr Polym; 2024 Apr; 329():121795. PubMed ID: 38286559
[TBL] [Abstract][Full Text] [Related]
7. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
[TBL] [Abstract][Full Text] [Related]
8. GSH-activable heterotrimeric nano-prodrug for precise synergistic therapy of TNBC.
Zhang X; Chen Y; Tang J; Chen C; Sun Y; Zhang H; Qiao M; Jin G; Liu X
Biomed Pharmacother; 2024 Apr; 173():116375. PubMed ID: 38460372
[TBL] [Abstract][Full Text] [Related]
9. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
[TBL] [Abstract][Full Text] [Related]
10. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel/sunitinib-loaded micelles promote an antitumor response in vitro through synergistic immunogenic cell death for triple-negative breast cancer.
Qin T; Xu X; Zhang Z; Li J; You X; Guo H; Sun H; Liu M; Dai Z; Zhu H
Nanotechnology; 2020 Sep; 31(36):365101. PubMed ID: 32434167
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.
He X; Zhang J; Li C; Zhang Y; Lu Y; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Guo Q; Sun T; Cheng J; Jiang C
Theranostics; 2018; 8(18):4884-4897. PubMed ID: 30429875
[TBL] [Abstract][Full Text] [Related]
13. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
15. Au-Fe
Wei R; Fu G; Li Z; Liu Y; Qi L; Liu K; Zhao Z; Xue M
J Colloid Interface Sci; 2024 Jun; 663():644-655. PubMed ID: 38430834
[TBL] [Abstract][Full Text] [Related]
16. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
17. A multi-mode Rhein-based nano-platform synergizing ferrotherapy/chemotherapy-induced immunotherapy for enhanced tumor therapy.
Zhu X; Xie L; Tian J; Jiang Y; Song E; Song Y
Acta Biomater; 2024 May; 180():383-393. PubMed ID: 38570106
[TBL] [Abstract][Full Text] [Related]
18. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
Shetake NG; Das SK; Kumar A; Pandey BN
Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
[TBL] [Abstract][Full Text] [Related]
19. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis.
Li Y; Xiao Y; Lin HP; Reichel D; Bae Y; Lee EY; Jiang Y; Huang X; Yang C; Wang Z
Biomaterials; 2019 Jan; 188():160-172. PubMed ID: 30352320
[TBL] [Abstract][Full Text] [Related]
20. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
Song X; Wang X; Chen X; Yu Z; Zhou Y
J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
